Ajanta Pharma
NSE:AJANTAMumbai, India· Est.
Indian‑based specialty pharma delivering branded generics and complex dosage forms worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
Indian‑based specialty pharma delivering branded generics and complex dosage forms worldwide.
CardiovascularCentral Nervous SystemAnti-infectivesGastrointestinalOncology
Technology Platform
Advanced formulation development and process engineering for complex dosage forms, supported by FDA‑ and WHO‑approved manufacturing facilities and a strong R&D team.
Opportunities
Expansion into high‑growth emerging markets and increased US generic market share leveraging FDA‑approved facilities; potential entry into biosimilars and specialty niche segments.
Risk Factors
Regulatory changes, price erosion in the generics market, and intense competition from larger Indian generic manufacturers.
Competitive Landscape
Faces competition from Indian giants such as Sun Pharma, Cipla, and Dr. Reddy’s, but differentiates through first‑to‑market launches, complex dosage form expertise, and robust quality certifications.